Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yolanda Mueller is active.

Publication


Featured researches published by Yolanda Mueller.


Tobacco Control | 2007

Effectiveness of biomedical risk assessment as an aid for smoking cessation: a systematic review

Raphaël Bize; Bernard Burnand; Yolanda Mueller; Jacques Cornuz

Objective: To determine the efficacy of biomedical risk assessment (eg, exhaled carbon monoxide (CO), or genetic susceptibility to lung cancer) as an aid for smoking cessation. Data sources: Cochrane Tobacco Addiction Group Specialized Register, Cochrane Central Register of Controlled Trials, Medline (1966–2004) and EMBASE (1980–2004). Study selection: Randomised controlled smoking cessation interventions using biomedical tests with at least 6 months follow-up. Data extraction: Two reviewers independently screened all search results (titles and abstracts) for possible inclusion. Each reviewer then extracted data from the selected studies, and assessed their methodological quality based on the CONSORT (Consolidated Standards of Reporting Trials) statement criteria. Data synthesis: Of 4049 retrieved references, eight trials were retained for data extraction and analysis. Three trials isolated the effect of exhaled CO on smoking cessation rates resulting in the following ORs and 95% CIs: 0.73 (0.38 to 1.39), 0.93 (0.62 to 1.41) and 1.18 (0.84 to 1.64). Measurement of exhaled CO and spirometry were used together in three trials, resulting in the following ORs (95% CI): 0.60 (0.25 to 1.46), 2.45 (0.73 to 8.25) and 3.50 (0.88 to 13.92). Spirometry results alone were used in one other trial with an OR (95% CI) of 1.21 (0.60 to 2.42). Ultrasonography of carotid and femoral arteries performed on light smokers gave an OR (95% CI) of 3.15 (1.06 to 9.31). Conclusions: Scarcity and limited quality of the current evidence does not support the hypothesis that biomedical risk assessment increases smoking cessation as compared with the standard treatment.


Computer Methods and Programs in Biomedicine | 2007

www.fevertravel.ch: An online study prototype to evaluate the safety and feasibility of computerized guidelines for fever in returning travellers and migrants

Anne-Emmanuelle Ambresin; Valérie D'Acremont; Yolanda Mueller; Olivier Martin; B. Burnand; Blaise Genton

Following the paper publication of practice guidelines for the management of febrile patients returning from the tropics, we constructed a consultation website that comprises a decision chart and specific diagnostic features providing medical diagnostic assistance to primary care physicians. We then integrated a research component to evaluate the implementation of these computerized guidelines. This study website has the same interface as the consultation website. In addition, one is able to record: (i) the pathway followed by the physician through the decision chart, (ii) the diagnostic tests performed, (iii) the initial and final diagnoses as well as outcome and (iv) reasons for non-adherence when the physician diverges from the proposed attitude. We believe that Internet technology is a powerful medium to reach physicians of different horizons in their own environment, and could prove to be an effective research tool to disseminate practice guidelines and evaluate their appropriateness. Here we describe the design, content, architecture and system implementation of this interactive study prototype aimed at integrating operational research in primary care practice.


Scandinavian Journal of Primary Health Care | 2018

Burden of cardiovascular disease across 29 countries and GPs’ decision to treat hypertension in oldest-old

Sven Streit; Jacobijn Gussekloo; Robert A. Burman; Claire Collins; Biljana Gerasimovska Kitanovska; Sandra Gintere; Raquel Gómez Bravo; Kathryn Hoffmann; Claudia Iftode; Kasper L. Johansen; Ngaire Kerse; Tuomas H. Koskela; Sanda Kreitmayer Peštić; Donata Kurpas; Christian D. Mallen; Hubert Maisonneuve; Christoph Merlo; Yolanda Mueller; Christiane Muth; Rafael H. Ornelas; Marija Petek Šter; Ferdinando Petrazzuoli; Thomas Rosemann; Martin Sattler; Zuzana Švadlenková; Athina Tatsioni; Hans Thulesius; Victoria Tkachenko; Péter Torzsa; Rosy Tsopra

Abstract Objectives: We previously found large variations in general practitioner (GP) hypertension treatment probability in oldest-old (>80 years) between countries. We wanted to explore whether differences in country-specific cardiovascular disease (CVD) burden and life expectancy could explain the differences. Design: This is a survey study using case-vignettes of oldest-old patients with different comorbidities and blood pressure levels. An ecological multilevel model analysis was performed. Setting: GP respondents from European General Practice Research Network (EGPRN) countries, Brazil and New Zeeland. Subjects: This study included 2543 GPs from 29 countries. Main outcome measures: GP treatment probability to start or not start antihypertensive treatment based on responses to case-vignettes; either low (<50% started treatment) or high (≥50% started treatment). CVD burden is defined as ratio of disability-adjusted life years (DALYs) lost due to ischemic heart disease and/or stroke and total DALYs lost per country; life expectancy at age 60 and prevalence of oldest-old per country. Results: Of 1947 GPs (76%) responding to all vignettes, 787 (40%) scored high treatment probability and 1160 (60%) scored low. GPs in high CVD burden countries had higher odds of treatment probability (OR 3.70; 95% confidence interval (CI) 3.00–4.57); in countries with low life expectancy at 60, CVD was associated with high treatment probability (OR 2.18, 95% CI 1.12–4.25); but not in countries with high life expectancy (OR 1.06, 95% CI 0.56–1.98). Conclusions: GPs’ choice to treat/not treat hypertension in oldest-old was explained by differences in country-specific health characteristics. GPs in countries with high CVD burden and low life expectancy at age 60 were most likely to treat hypertension in oldest-old. Key Points  • General practitioners (GPs) are in a clinical dilemma when deciding whether (or not) to treat hypertension in the oldest-old (>80 years of age).  • In this study including 1947 GPs from 29 countries, we found that a high country-specific cardiovascular disease (CVD) burden (i.e. myocardial infarction and/or stroke) was associated with a higher GP treatment probability in patients aged >80 years.  • However, the association was modified by country-specific life expectancy at age 60. While there was a positive association for GPs in countries with a low life expectancy at age 60, there was no association in countries with a high life expectancy at age 60.  • These findings help explaining some of the large variation seen in the decision as to whether or not to treat hypertension in the oldest-old.


Scandinavian Journal of Primary Health Care | 2018

Swiss students and young physicians want a flexible goal-oriented GP training curriculum.

Zsofia Rozsnyai; Kali Tal; Marius Bachofner; Hubert Maisonneuve; Cora Nina Moser-Bucher; Yolanda Mueller; Nathalie Scherz; Sebastien Martin; Sven Streit

Abstract Background: A growing shortage of general practitioners (GPs), in Switzerland and around the world, has forced countries to find new ways to attract young physicians to the specialty. In 2017, Switzerland began to fund hundreds of new study places for medical students. This wave of young physicians will soon finish University and be ready for postgraduate training. We hypothesized that an attractive postgraduate training program would encourage interested young physicians to pursue a GP career. Methods: This is a cross-sectional survey of young physicians from the Swiss Young General Practitioners Association (JHaS), members of Cursus Romand de médecine de famille (CRMF), and all current medical students (5th or 6th years) (n = 554) in Switzerland, excluding students indicating definitely not to become GPs. We asked all if they were likely to become a GP (Likert: 1-10), and then asked them to score general features of a GP training curriculum, and likely effects of the curriculum on their career choice (Likert scale). They then rated our model curriculum (GO-GP) for attractiveness and effect (Likert Scales, open questions). Results: Most participants thought they would become GPs (Likert: 8 of 10). Over 90% identified the same features as an important part of a curriculum (“yes” or “likely yes”): Our respondents thought the GO-GP curriculum was attractive (7.3 of 10). It was most attractive to those highly motivated to become GPs. After reviewing the curriculum, most respondents (58%) felt GO-GP would make them more likely to become a GP. Almost 80% of respondents thought an attractive postgraduate training program like GO-GP could motivate more young physicians to become GPs. Conclusions: Overall, medical students and young physicians found similar features attractive in the general and GO-GP curriculum, regardless of region or gender, and thought an attractive curriculum would attract more young doctors to the GP specialty. Key points An attractive postgraduate training program in general practice can attract more young physicians to become GPs. In this study cross-sectional survey including medical students (n = 242) and young physicians (n = 312) we presented general features for a curriculum and a model curriculum for general practice training, for evaluation of attractiveness to our study population. General practice training curriculum provides flexibility in choice of rotations, access to short rotations in a wide variety of medical specialties, training in specialty practices as well, mentoring and career guidance by GPs and guidance in choosing courses/certificate programs necessary for general practice. These findings help building attractive postgraduate training programs in general practice and fight GP shortage.


Cochrane Database of Systematic Reviews | 2012

Biomedical risk assessment as an aid for smoking cessation

Raphaël Bize; Bernard Burnand; Yolanda Mueller; Myriam Rège‐Walther; Jean‐Yves Camain; Jacques Cornuz


BMC Geriatrics | 2017

Variation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countries

Sven Streit; Marjolein Verschoor; Nicolas Rodondi; Daiana Bonfim; Robert A. Burman; Claire Collins; Gerasimovska Kitanovska Biljana; Sandra Gintere; Raquel Gómez Bravo; Kathryn Hoffmann; Claudia Iftode; Kasper L. Johansen; Ngaire Kerse; Tuomas H. Koskela; Sanda Kreitmayer Peštić; Donata Kurpas; Christian D. Mallen; Hubert Maisoneuve; Christoph Merlo; Yolanda Mueller; Christiane Muth; Marija Petek Šter; Ferdinando Petrazzuoli; Thomas Rosemann; Martin Sattler; Zuzana Švadlenková; Athina Tatsioni; Hans Thulesius; Victoria Tkachenko; Péter Torzsa


Journal of Travel Medicine | 2014

Feasibility and Clinical Outcomes When Using Practice Guidelines for Evaluation of Fever in Returning Travelers and Migrants: A Validation Study

Yolanda Mueller; Valérie D'Acremont; Anne-Emmanuelle Ambresin; Isabelle Rossi; Olivier Martin; Bernard Burnand; Blaise Genton


Schweizerische Ärztezeitung | 2018

Das Programm Multimorbidität in der Hausarztmedizin

Lilli Herzig; Yolanda Mueller; Andreas Zeller; Sven Streit; Dagmar M. Haller; Stefan Neuner-Jehle; Nicolas Senn


Bulletin des Médecins Suisses | 2018

Le programme Multi Morbidité en Médecine de Famille

Lilli Herzig; Yolanda Mueller; Andreas Zeller; Sven Streit; Dagmar M. Haller; Stefan Neuner-Jehle; Nicolas Senn


British Journal of General Practice | 2018

Diagnosis and treatment of community-acquired pneumonia in patients with acute cough: a quantitative study of decision thresholds in primary care

Mark H. Ebell; Isabella Locatelli; Yolanda Mueller; Nicolas Senn; Kathryn Morgan

Collaboration


Dive into the Yolanda Mueller's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Blaise Genton

Swiss Tropical and Public Health Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge